Digitek Medical Injury Lawsuits Filed in Orange County, Texas
Four medical injury lawsuits have been filed in Orange County, Texas against Mylan Pharmaceuticals over the cardiac drug, Digitek. The lawsuits relate to injuries caused by Digitek tablets that contained a double strength dose of the active ingredient, Digoxin.
The double strength Digitek tablets were the subject of a massive recall in April 2008. The Food and Drug Administration (FDA) announced a Class I nationwide recall of all lots of Digitek, manufactured by Mylan Bertek Pharmaceutical Inc. and UDL Laboratories that year. Earlier, the FDA issued warnings to Mylan and UDL for failure to file regular safety reports at their New Jersey manufacturing facility. In February 2007, the FDA issued a second warning claiming that there were faulty manufacturing practices at the company. The medical injury lawsuit claims damages for “physical pain” the plaintiffs suffered after taking the double dose tablets.
Digitek Lawsuits
Digoxin, which is the main active ingredient in Digitek tablets, improves the heart's ability to pump blood, in case of heart failure. It is used to treat a range of cardiac problems, including accelerated or irregular heartbeat, heart failure, dizziness or palpitations. 
While it is very effective in the treatment of atrial flutter and other heart conditions, an overdose of Digoxin can have serious consequences on a person's health. Digoxin overdose can quickly lead to digitalis toxicity, whose symptoms include dizziness, blurred vision and other medical issues. In extreme cases, the victim can suffer from a decreased heart rate, pulse irregularities and palpitations. Digitalis toxicity can also impact the functioning of the kidneys. It is therefore an especially dangerous condition in patients who already suffer from kidney and renal disorders. Patients who took the double dose Digitek tablets were at risk of an overdose. The companies involved in producing the double dose tablets including Mylan Bertek Pharmaceuticals Inc, UDL Laboratories Inc., and Actavis Totowa have yet to provide solid explanations for why so many lots of these tablets contained twice the recommended dosage.
Medical Injury Lawyers
Pharmaceutical negligence can leave patients at risk for adverse reactions, side effects, and as in the Digitek case, over-dosage. Pursuing claims against these big name companies requires access to financial and medico-legal resources. Often, only specialized medical injury attorneys have access to these resources.
If you have been by the use of a defective pharmaceutical drug, contact a Texas medical injury attorney at Arnold & Itkin LLP for a free consultation.
